FigureĀ 2.
Pharmacokinetics of emicizumab prophylaxis. Mean (95% CI) emicizumab trough concentration at visit (A) over time and (B) based on age at visit during the maintenance period. For the participant whose dose was up-titrated, only data before up-titration are included. For the analysis according to the age, only samples from week 5 onwards (maintenance period) were considered.